Xilio Therapeutics
XLO
#9617
Rank
NZ$68.25 M
Marketcap
$1.32
Share price
-5.23%
Change (1 day)
-24.60%
Change (1 year)

EPS for Xilio Therapeutics (XLO)

EPS in 2023 (TTM): -$5.02

According to Xilio Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.15. In 2022 the company made an earnings per share (EPS) of -$5.41 a decrease over its 2021 EPS that were of -$5.18.

EPS history for Xilio Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.02-7.09%
2022-$5.414.42%
2021-$5.18